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Glycoprotein-deleted (DG) rabies virus is a powerful
tool for studies of neural circuit structure. Here, we
describe thedevelopment anddemonstrate the utility
of new resources that allow experiments directly
investigating relationships between the structure
and function of neural circuits. New methods and
reagents allowed efficient production of 12 novel
DG rabies variants from plasmid DNA. These new
rabies viruses express useful neuroscience tools,
including the Ca2+ indicator GCaMP3 for monitoring
activity; Channelrhodopsin-2 for photoactivation;
allatostatin receptor for inactivation by ligand appli-
cation; and rtTA, ERT2CreERT2, or FLPo, for control
of gene expression. These new tools allow neurons
targeted on the basis of their connectivity to have
their function assayedor their activity or gene expres-
sion manipulated. Combining these tools with in vivo
imaging and optogenetic methods and/or inducible
gene expression in transgenic mice will facilitate
experiments investigating neural circuit develop-
ment, plasticity, and function that have not been
possible with existing reagents.
INTRODUCTION
Over many decades, neuroscientists have sought to understand
how diverse neurons in the central nervous system generate
perception and behavior. The functions of the brain are based
on the activity patterns of large numbers of interconnected neu-
rons that form neural circuits. Much progress has been made in
electrophysiology, electron microscopy, optical imaging, and
molecular biology to understand how a neuron’s connectivity
contributes to its function in the circuit. Genetic tools delivered
by viral vectors or in transgenic animals have become a powerful
resource for studies of the structure and function of neuronal
networks (Arenkiel and Ehlers, 2009; Luo et al., 2008; Scanziani
and Ha¨usser, 2009). These tools can be used to change gene
expression, to monitor or manipulate neural activity, and to traceneuronal connectivity. Such studies are becoming increasingly
sophisticated as a result of the combinatorial power allowed
by the incorporation of multiple tools. For example, it is possible
to identify the connections or function of specific cell types
or a single cell, and by incorporating genetic tools into tracing
viruses, it is possible to more directly link circuits and func-
tion (Boldogkoi et al., 2009; Choi et al., 2010; DeFalco et al.,
2001; Haubensak et al., 2010; Luo et al., 2008; Marshel et al.,
2010; Miyamichi et al., 2011; Rancz et al., 2011; Stepien
et al., 2010; Wall et al., 2010; Wickersham et al., 2007b; Zhou
et al., 2009).
Rabies virus is particularly useful for the study of neuronal
circuits because of its ability to spread transsynaptically, exclu-
sively in the retrograde direction (Callaway, 2008; Ugolini, 1995,
2010). Relative to other tracing viruses, such as one particular
strain of herpes virus called pseudorabies virus (PRV) and other
herpes viruses, it is unique in that infected cells remain viable
for weeks (Wickersham et al., 2007a), and it can amplify from
even a single viral particle (Coulon et al., 1982). It has been
shown that a glycoprotein-deleted (DG) variant of the SAD-
B19 strain of rabies virus encoding GFP (SADDG-GFP) can
be used to reveal the detailed morphology of infected projec-
tion neurons (Larsen et al., 2007; Nassi and Callaway, 2007;
Wickersham et al., 2007a), that EnvA-pseudotyped SADDG-
GFP rabies viruses can be used to selectively label the direct
inputs to a targeted neuronal population or even a single
neuron (Haubensak et al., 2010; Marshel et al., 2010; Miyamichi
et al., 2011; Rancz et al., 2011; Stepien et al., 2010; Wall
et al., 2010; Wickersham et al., 2007b; Yonehara et al., 2011),
and that a combination of EnvB-pseudotyped rabies viruses
and a bridge protein with TVB can selectively target infection
to specific neuron types that bind to the bridge protein (Choi
et al., 2010).
While DG rabies viruses have already proven to be a powerful
tool for revealing neural circuit structure, understanding how
neural circuits develop and function requires direct links to be
made between neural circuits, activitymonitoring, andmanipula-
tion of activity or gene expression. We therefore aimed to
extend the utility of a recombinant rabies virus by incorporating
the potential to exploit other novel genetic technologies that
have recently been pioneered. For example, much progress
has been made at the interface of optical and genetic tech-
nologies (Luo et al., 2008; Scanziani and Ha¨usser, 2009). In vivoNeuron 71, 617–631, August 25, 2011 ª2011 Elsevier Inc. 617
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with indicator dyes allows monitoring of activity from many
neurons simultaneously (Kerr et al., 2005; Ohki et al., 2005;
Runyan et al., 2010; Svoboda and Yasuda, 2006), and the
incorporation of genetically-encoded calcium indicators allows
the monitoring of genetically-targeted neurons (Miyawaki,
2005; Tian et al., 2009). Genetic strategies for activating or in-
activating selected neurons have also opened up new possibil-
ities for understanding circuitry and behavior. In particular,
optical stimulation, or optogenetics, has allowed for manipula-
tion of the activity of genetically-defined neurons with high
temporal and spatial resolution (Boyden et al., 2005; Cardin
et al., 2009; Sohal et al., 2009). Finally, the last decade has
seen the development of a large number of floxed, fretted, or
tTA-dependent mouse lines (Branda and Dymecki, 2004) and
viral vectors (Kuhlman andHuang, 2008; Luo et al., 2008) to allow
selective and inducible knockout of genes of interest, allowing
investigations of the roles of particular genes in the development,
plasticity, or function of defined components of the nervous
system. By incorporating each of these classes of genetic
tools into the DG rabies viruses, it is possible to combine their
power with the ability to target connectionally-defined neuronal
networks.
Although rabies viruses are a powerful tool, the fact that rabies
is a negative strand RNA virus presents both unique challenges
and opportunities for the production and the use of new variants
to interface with the growing arsenal of genetic tools and trans-
genic mouse lines. For example, DNA viruses, such as PRV, can
be readily recovered following manipulation of the viral genome
and expression of encoded genes can bemade conditional upon
interaction with recombinase expressed in transgenic mouse
lines (DeFalco et al., 2001). In contrast, recovery of new rabies
virus variants requires a more complex process (Inoue et al.,
2003; Ito et al., 2003; Schnell et al., 1994; Wu and Rupprecht,
2008), and the ability to interface with transgenic mice requires
development of novel strategies, as described below. Neverthe-
less, once a new DG rabies virus variant is successfully recov-
ered, it can easily be propagated and amplified in a rabies
glycoprotein-expressing cell line (Etessami et al., 2000; Mebat-
sion et al., 1996; Wickersham et al., 2007a; Wickersham et al.,
2007b).
Here we establish reliable and efficient methods and reagents
for recovery and amplification of rabies virus and describe the
development and validation of the new SADDG variants that
we have produced. These variants include SADDG rabies
viruses encoding red fluorescent proteins; blue fluorescent
proteins; both red and green fluorescent proteins from the
same genome; the calcium sensor GCaMP3 for monitoring
neuronal activity (Tian et al., 2009); the light-gated cation channel
channelrhodposin-2 (ChR2) for the activation of neural activity
(Boyden et al., 2005); the Drosophila allatostatin receptor (AlstR)
for silencing of neural activity (Lechner et al., 2002; Tan et al.,
2006); and the reverse tetracycline transactivator (rtTA), tamox-
ifen-inducible Cre-recombinase, and flippase (FLP)-recombi-
nase to allow control of gene expression in available transgenic
mouse lines and viral vectors (Branda and Dymecki, 2004). We
illustrate the utility of these variants and further discuss an
even wider potential range of powerful applications.618 Neuron 71, 617–631, August 25, 2011 ª2011 Elsevier Inc.RESULTS
System for Recovery of DG Rabies Viruses
from Plasmid DNA
Although SADDG-GFP can be recovered from DNA plasmids
and amplified using previously established procedures (Buch-
holz et al., 1999), we aimed to improve the efficiency ofDG rabies
virus recovery from DNA. Here, we generated new plasmids and
cell lines and tested various culture conditions to optimize
recovery systems. Because rabies is a negative strand RNA virus
but the tools that are available to manipulate genetic material
work with DNA, it is necessary to generate and use several
specialized reagents in order to recover new genetically-modi-
fied rabies variants from a set of DNA plasmids. At least four
different groups have developed and used such systems to
recover various rabies strains (Inoue et al., 2003; Ito et al.,
2003; Schnell et al., 1994; Wu and Rupprecht, 2008). The first
published system recovered the SAD-B19 strain of rabies
virus, utilized transcription from the T7 promoter, required T7
RNA polymerase provided by a vaccinia helper virus (Schnell
et al., 1994), and in later developments was supported by
a cell line expressing T7 polymerase (BSR T7/5) (Buchholz
et al., 1999; Wickersham et al., 2007b) to replace vaccinia. This
system was used in all previous studies recovering DG rabies
virus. Intact HEP-Flury rabies virus has also been recovered
with transcription from the CMV promoter and did not require
T7 polymerase (Inoue et al., 2003). Previous studies have not
determined whether such a system can be used to efficiently
recover DG rabies viruses or the SAD-B19 strain.
To generate the new rabies variants described here, we inde-
pendently developed a hybrid system for recovery of SADDG
rabies virus, incorporating both CMV and T7 promoters, similar
to a system for recovery of the ERA strain of rabies virus (Wu
and Rupprecht, 2008). The recovery system is composed of
a rabies virus genomic plasmid (pcDNA-SADDG-GFP) contain-
ing the full-length genome of the SAD-B19 strain of rabies virus
with the glycoprotein gene deleted and replaced with GFP
(SADDG-GFP) and a set of helper plasmids for expression of viral
genes required to recover virus. In pcDNA-SADDG-GFP, the
genomic sequence was flanked by hammerhead ribozyme
(HamRz) (Le Mercier et al., 2002) and hepatitis delta ribozyme
(HdvRz) (Symons, 1992) and expression was under the control
of both the CMV promoter and the T7 RNA polymerase
promoter. Helper plasmids encoded individual viral genes that
were also controlled by both CMV and T7 promoters. All of the
above plasmids were constructed following reverse transcrip-
tion from the parent virus SADDG-GFP (Wickersham et al.,
2007a).
We tested the importance of T7 RNA polymerase expression,
the relative utility of three different cells lines, and two different
transfection methods to quantitatively compare the success
rates of different recovery strategies using these reagents.
Conditions under which T7 polymerase was expressed included
the use of the T7-expressing cell line BSR T7/5 (Buchholz
et al., 1999), or HEK293t or BHK-21 cells transfected with a
plasmid to induce expression of T7 RNA polymerase with a
nuclear localization signal (Wu and Rupprecht, 2008). In these
cases, we attempted to recover SADDG-GFP by transfecting
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a calcium phosphate method, and cells were cultured in 5%CO2
at 37C. SADDG-GFP rabies virus could be successfully recov-
ered under all conditions in which T7 polymerase was expressed
but was never recovered in the absence of T7 polymerase. The
highest rate of recovery was achieved using the BSR T7/5 cells
(50.0%, three of six attempts), while success was less than
half as likely with HEK293t (16.7%, one of six) or BHK-21 cells
(16.7%, one of six) transfected with T7 polymerase. The require-
ment for T7 polymerase expression with our system contrasts
with successful T7 polymerase-independent recovery of intact
HEP-Flury rabies virus (Inoue et al., 2003). This difference could
be because of differences in the strain of rabies virus, the pres-
ence of glycoprotein in the viral genome, or other differences in
the reagents and methods used.
While the moderate success rates with this system were
adequate for recovery of rabies viruses expressing fluorescent
proteins, they were still relatively inefficient. Furthermore, we
found that it was not possible to recover the ChR2-mCherry virus
using these methods. We reasoned that because recovery effi-
ciency is likely dependent on the expression of both T7 poly-
merase and B19G, it would be helpful to stably express both of
these genes in producer cells. We therefore established new
packaging cells expressing both T7 RNA polymerase and the
rabies glycoprotein. BSR T7/5 cells expressing T7 RNA poly-
merase were infected with the HIV lentivirus encoding both
Histone2B-tagged GFP and rabies glycoprotein B19G linked
by an F2A self-cleaving element under the control of CMV
promoter. Infected cells expressed GFP in their cell nuclei, and
6.2% of total cells were collected as a GFP-high+ fraction using
FACS sorting (Figure S1A, available online). The FACS-sorted
cells expressed T7 RNA polymerase, B19G, and GFP (referred
to hereafter as B7GG cells) (Figure S1B). Using the B7GG cells,
we tested various parameters, including plasmid concentra-
tions, transfection reagents, and culture conditions, to increase
the efficiency of recovery and amplification of DG rabies viruses.
Under 35C and 3% CO2 conditions, B7GG cells decreased
proliferation and remained healthier for about 1 week compared
to their condition under standard culture conditions (37C and
5% CO2). When B7GG cells were transfected with the rabies
genomic plasmid carrying GFP (pSADDG-GFP-F2) and helper
plasmids carrying B19N, B19P, B19L, and B19G with Lipofecta-
min2000 in a humidified atmosphere of 3% CO2 at 35
C, the
success rate of recovery was 100% (six wells were examined
in one set of experiments; the reproducibility of the results was
confirmed in four independent sets of experiments), significantly
higher than with the first established protocol (BSR T7/5 cells
with a calcium phosphate method under 37C and 5% CO2
conditions; 37.4 ± 8.0%; p < 0.01, t test). Furthermore, the titer
of virus recovered by the new protocol (B7GG cells with
Lipofectamine2000 under 35C and 3% CO2 conditions) was
more than ten times higher than with the earlier protocol (BSR
T7/5 cells with a calcium phosphate method under 37C and
5% CO2 conditions). Therefore, 35
C and 3% CO2 conditions
markedly increased both the recovery efficiency after transfec-
tion and further amplification, allowing for efficient recovery of
viruses expressing membrane proteins, such ChR2 and AlstR
(see below).Generation of DG Rabies Viral Vectors Encoding
Multiple Exogenous Genes
We next produced versions of DG rabies viruses expressing
various fluorescent proteins because combinations of different
colors are indispensable, for example, for interfacing with
GFP-expressing mouse lines or for combined injections of
different viruses. We replaced B19G in the rabies genome
with a red fluorescent protein, DsRed2 (SADDG-DsRed2),
mCherry (SADDG-mCherry, Figure 1A), c-Myc epitope-tagged
mCherry (SADDG-mCherry-Myc), or a blue fluorescent protein,
BFP (SADDG-BFP Figure 1B). These viruses were recovered
from DNA, amplified, and concentrated by ultracentrifugation.
The titers to which these viruses could be grown and concen-
trated were indistinguishable from the original SADDG-GFP
(Table 1). Concentrated SADDG-mCherry was tested in vivo
by injection into the dorsal lateral geniculate nucleus (dLGN)
of rats (Figure 1A) or into two strains of glutamic acid decarbox-
ylase (GAD)-GFP mice which express GFP in cortical interneu-
rons (GIN) (Oliva et al., 2000) in Figure S2A and G30 (Lo´pez-
Bendito et al., 2004) in Figure S2B). As expected on the basis
of previously published studies that used SADDG-GFP injections
into the thalamus (Larsen et al., 2007), following 3 days survival,
cortical neurons in locations known to project to the dLGN were
infected and completely filled with mCherry, and this allowed
clear visualization of detailed neuronal morphology, including
dendritic spines and axons (Figure 1A). Injections of SADDG-
mCherry into dLGN of GAD-GFP mouse lines further demon-
strated that infection was restricted from cortical inhibitory
neurons that do not project to dLGN, and the GFP interneurons
could be clearly distinguished from the rabies-virus-infected,
mCherry-expressing corticothalamic projection neurons in the
primary visual cortex (V1) (Figures S2A and S2B). When we
injected SADDG-BFP into the rat V1, nearby neurons in layers
2/3 and 4 of the V1 were labeled with BFP (Figure 1B). Similar
results were observed for SADDG-mCherry-Myc (Figure S3).
For many applications, it is important to be able to mark in-
fected neurons with one gene and to also express a second
gene that, for example, controls cell function. This strategy is
often preferable to the use of fusion proteins, because incorpo-
ration of a marker protein can prevent normal function, or in
cases in which the gene product might be targeted to membrane
compartments so that cell morphology is not easily visualized.
Because DG rabies viruses expressing multiple exogenous
genes have not been reported previously and the genome loca-
tion of our inserts differed from that in previous two-gene viruses
(McGettigan et al., 2003; Ohara et al., 2009; Schnell et al., 2000),
we were concerned that possible complications related to tran-
scriptional regulation or viral capacity might prevent successful
recovery and/or coexpression of both genes. We therefore
sought to recoverDG rabies virus encoding two different fluores-
cent proteins GFP andmCherry. This allowed direct visualization
of whether both genes were reliably coexpressed. Two-gene
expression was achieved by introduction of a second gene into
an independent open reading frame in the SADDG-GFP genome.
The novel genes were introduced along with endogenous tran-
scriptional control elements to take advantage of the rabies virus
RNA-dependent RNA polymerase, which assures segmentation
of separate genomic transcripts. Transcription stop/start signalsNeuron 71, 617–631, August 25, 2011 ª2011 Elsevier Inc. 619
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Figure 1. Production of Rabies Viral Vectors En-
coding Multiple Genes
(A and B) Generation of SADDG-mCherry (A) and SADDG-
BFP (B) rabies viruses. (A) Neurons in layer 6 of the rat
primary visual cortex were visualized after injection of
SADDG-mCherry into the dLGN. (B) Neurons in layers 2/3
and 4 of rat visual cortex were labeled with SADDG-BFP
by injection into the nearby visual cortex. Scale bars
represent 100 mm.
(C) Each open reading frame requires transcription start
and stop sequences to be inserted before and after the
open reading frame in the rabies genome. To insert an
additional exogenous gene, the mCherry coding
sequence preceded by additional transcription start and
stop sequences (black with red outlines) was inserted
between the last codon of GFP and its transcription end
sequence.
(D–F) Neurons in cortical slice cultures infected with
SADDG-GFP-mCherry. All of the neurons infected with
SADDG-GFP-mCherry express both mCherry (D and F)
and GFP (E and F), indicating reliable transcriptional
regulation and expression of both gene products. Scale
bar represents 100 mm.
(G) Plasmid created for efficient introduction of one or two
transgenes into the rabies genome. The pSADDG-F3
rabies genome vector has two multiple cloning sites
(MCS-1 and MCS-2) for insertion of genes of interest. For
expression of a single gene from rabies vectors, use of one
site in MCS-1 and one site in MCS-2 enables insertion of
a single ORF and deletion of stop and start transcription
cassettes. For cloning of two transgenes, insertion of each
gene in MCS-1 and MCS-2 allows reliable coexpression
from the rabies vectors.
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B19 genome (McGettigan et al., 2003; Ohara et al., 2009; Schnell
et al., 2000) were placed upstream of an mCherry ORF, and this
was then inserted into pcDNA-SADDG-GFP between the stop
codon of GFP and transcription stop signal of GFP to create
pcDNA-SADDG-GFP-mCherry (Figure 1C). We recovered the
GFP- and mCherry-expressing rabies virus (SADDG-GFP-
mCherry) from the plasmid pcDNA-SADDG-GFP-mCherry and
then tested the virus in cortical slice cultures. GFP and mCherry
expression patterns confirmed that the rabies virus expressed
both genes reliably and at high levels in the same neurons
(Figures 1D–1F). Thus, to express two different transgenes
from the rabies genome, we used the same transcription stop
and start sequences in subsequent experiments requiring620 Neuron 71, 617–631, August 25, 2011 ª2011 Elsevier Inc.expression of multiple genes. Finally, we de-
signed a new rabies genome vector to efficiently
introduce one gene or two genes (pSADDG-F3).
The pSADDG-F3 has two multiple-cloning sites
(MCS-1 and MCS-2), which flank the transcrip-
tion stop and start sequence cassette in the
rabies genome (Figure 1G).
Monitoring of Neural Activity with
Genetically-Encoded Calcium Indicators
Genetically-encoded calcium indicators enable
neuroscientists to examine the function ofgenetically-defined neuronal populations (Luo et al., 2008; Miya-
waki, 2005; Tian et al., 2009). To facilitate studies linking circuit
structure and function, we produced DG rabies viruses express-
ing the genetically-encoded calcium sensor GCaMP3 (Tian et al.,
2009). As described above for viruses expressing fluorescent
proteins, we produced two new rabies virus variants encoding
GCaMP3. The first of these viruses expresses only GCaMP3 in
place of B19G (SADDG-GCaMP3), while the second expresses
both GCaMP3 and DsRedX (SADDG-GCaMP3-DsRedX). We
recovered and amplified both SADDG-GCaMP3 and SADDG-
GCaMP3-DsRedX in B7GG cells under 35C, 3% CO2 condi-
tions, and concentrated the viruses for in vivo injection. Again,
titers of these viruses were indistinguishable from viruses encod-
ing GFP only (Table 1). To test whether SADDG-GCaMP3 is
Table 1. Titer and Transgene Size of Rabies Virus Variants
Name Gene 1 (Size) Gene 2 (Size) Titer
SADDG-GFP GFP (0.7 kb) ————— 5.8 3 108  7.5 3 109 (RG)
8.8 3 107  6.2 3 108 (EnvA)
SADDG-mCherry mCherry (0.7 kb) ————— 5.5 3 108  1.6 3 1010 (RG)
1.3 3 108  6.9 3 108 (EnvA)
SADDG-mCherry-Myc mCherry-Myc (1.0 kb) ————— 1.5 3 108  5.6 3 108 (RG)
SADDG-DsRed2 DsRed2 (0.7 kb) ————— 2.0 3 108  3.6 3 108 (RG)
SADDG-BFP BFP (0.7 kb) ————— 1.8 3 108  3.7 3 109 (RG)
SADDG-GFP-mCherry GFP (0.7 kb) mCherry (0.7 kb) 5.7 3 105  8.7 3 106
(RG, Supernatant)
SADDG-GCaMP3 GCaMP3 (1.4 kb) ————— 3.5 3 108  9.1 3 108 (RG)
SADDG-GCaMP3-DsRedX GCaMP3 (1.4 kb) DsRedX (0.7 kb) 3.7 3 108  7.5 3 108 (RG)
SADDG-ChR2-mCherry channelrhodopsin2-mCherry (1.6 kb) ————— 1.3 3 108  4.1 3 109 (RG)
SADDG-GFP-AlstR GFP (0.7 kb) allatostatin receptor (1.2 kb) 4.3 3 108  6.7 3 109 (RG)
SADDG-GFP-rtTA GFP (0.7 kb) rtTA (0.8 kb) 7.8 3 108  8.1 3 109 (RG)
2.9 3 105  4.9 3 105
(EnvA, supernatant)
SADDG-GFP-ERT2CreERT2 GFP (0.7 kb) ERT2CreERT2 (2.9 kb) 3.1 3 108  8.9 3 108 (RG)
SADDG-FLPo-DsRedX FLPo (1.3 kb) DsRedX (0.7 kb) 7.5 3 108  2.1 3 109 (RG)
Twelve new rabies virus variants and SADDGFP were produced in the present study. The transgenes, their size, and the titer of each DG rabies virus
used are listed. Unpseudotyped rabies viruses and EnvA-pseudotyped rabies viruses were titrated with HEK293t cells and HEK293-TVA cells, respec-
tively. Titers are expressed as infectious units/ml.
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GCaMP3 (Table 1) into the V1 of mice and later analyzed visual
responses of GCaMP3-expressing V1 neurons in vivo using
two-photon imaging. Figure S4A shows an anatomical recon-
struction of a selected V1 neuron imaged in vivo 11 days after
infection. Drifting gratings were presented in eight directions in
45 degree orientation steps in random order. Fluorescence
changes in the same cell were monitored during presentation
of visual stimuli. As illustrated in Figures S4B and S4C, visual
stimulation resulted in robust increases in fluorescence, the
strength of which depended on the grating orientation (a movie
of the response to the preferred orientation is available as Movie
S1). These results are similar to those described in mouse V1
using the calcium indicator dye Oregon Green BAPTA (OGB),
but the percent changes in fluorescence are much greater than
are typically observed with indicator dyes (Kerlin et al., 2010;
Runyan et al., 2010).
Although SADDG-GCaMP3 proved to be effective for moni-
toring activity of infected neurons, the numbers of infected
neurons that could be identified during in vivo two-photon
imaging was lower than expected from subsequent postmortem
examination (data not shown). We suspected that the difficulty in
identifying infected neurons in vivo resulted from relatively dim
baseline fluorescence, as expected from the dependence of
fluorescent intensity on baseline calcium levels (Kerlin et al.,
2010; Kerr et al., 2005; Ohki et al., 2005; Runyan et al., 2010).
Therefore, to facilitate in vivo identification of infected neurons,
we used SADDG-GCaMP3-DsRedX in subsequent studies and
first searched for expression of DsRedX before subsequent
characterization of functional responses based on the coexpres-
sion of GCaMP3. Furthermore, to allow functional characteriza-
tion of an identified subset of V1 neurons making connections toanother visual cortical area, we injected the SADDG-GCaMP3-
DsRedX into the anterolateral extrastriate cortical area (AL) of
mice and assessed visual responses of retrogradely infected
neurons in V1.
Injection of rabies virus into AL, subsequent identification of
V1, and alignment of two-photon imaging with the expected
location of retrogradely infected neurons was facilitated by
intrinsic signal imaging tomap retinotopy in V1 (Figure 2A) (Kalat-
sky and Stryker, 2003; see Methods for further details.). Nine
days after virus infection, blood vessel patterns were used to
select a location in V1 expected to provide input to the virus
injection location in AL (Figure 2A). Two-photon imaging at wave-
lengths sensitive to detection of DsRedX revealed a large field
of infected neurons in V1. Remarkably, infected neurons could
be clearly visualized to depths of750 mmbelow the pial surface
of the cortex (Figure 2B; the stack movie of SADDG-GCaMP3-
DsRedX-infected neurons in the V1 is available as Movie S2),
far deeper than is typically possible with imaging using OGB
(Kerlin et al., 2010; Kerr et al., 2005; Ohki et al., 2005; Runyan
et al., 2010). GCaMP3 was also visualized in all DsRedX-positive
cells and processes (Figure 2B).
We next selected planes of interest in the Z axis for imaging of
visually evoked functional changes in GCaMP3 fluorescence.
Figure 2C shows anatomical images at a depth of 370 mm from
the pial surface, while Figures 2D and 2E illustrate fluorescence
changes of GCaMP3 in selected cell bodies or dendrites in
response to visual stimuli. For visual stimulation, square-wave
gratings were drifted at 12 directions in 30 degree orientation
steps in random order. Infected V1 neurons exhibited significant
increases in the GCaMP3 fluorescence at particular grating
orientations. The two neuronal somata illustrated had direction
selective visual responses (Figures 2D1 and 2D2; A movie ofNeuron 71, 617–631, August 25, 2011 ª2011 Elsevier Inc. 621
Figure 2. Monitoring of Neural Activity with GCaMP3-Expressing DG Rabies Virus
(A) Retinotopic organization of the striate and extrastriate cortical regions. The retinotopic map from intrinsic imaging was overlaid on the image of surface blood
vessels. Location of the border between V1 and AL was identified on the basis of the representation of the vertical meridien (nasalmost visual fields) to allow
targeting of viral injections to AL (red X). SADDG-GCaMP3-DsRedX was injected into the lateral extrastriate cortical area AL of the mice, and the corresponding
retinotopic location in V1 was noted as the expected location of retrogradely infected neurons (red square).
(B) Z stack of SADDG-GCaMP3-DsRedX-infected neurons visualized in vivo with two-photon imaging of V1, 9 days after rabies injection. AL-projecting V1
neuronal cell bodies and processes could be seen in imaging planes extending from the cortical surface to a depth of 750 mm.
(C) Top view of two-photon laser-scanning images of SADDG-GCaMP3-DsRedX-infected neurons at a depth of 370 mm from the cortical surface. V1 neurons
were retrogradely labeled with SADDG-GCaMP3-DsRedX and coexpressed GCaMP3 (green) and DsRedX (red). Note that GCaMP3 could be seen in dendrites
and axons, as well as cell bodies. Scale bar represents 25 mm.
(D) Orientation selectivity of SADDG-GCaMP3-DsRedX-infected V1 neurons. (D1–D4) correspond to neuronal cell bodies (D1–D2) or dendrites (D3–D4) labeled 1–
4 in (C). Orientation tuning curves are plotted as the mean change in fluorescence of the cell body (D1 and D2) or dendritic segments (D3 and D4) during the entire
stimulus period in response to square-wave gratings presented at various orientations in a random order.
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Rabies Virus Variants for Neural Circuit Researchthe response to the preferred orientation in Figure 2D1 is avail-
able as Movie S3). Interestingly, orientation selective responses
were also detected from GCaMP3-labeled dendrites (Figures
2D3 and 2D4). It is likely that the combination of high expression
levels and sparse labeling with GCaMP3 (compared to dense
OGB labeling) contribute importantly to the ability to determine
visual responses of distinct neuronal processes.
The surprisingly clear label that could be observed in neurons
deep in the cortex suggested that these reagents might make it
possible to also measure their visual responses. We therefore
selected additional imaging planes at 520–535 mm below the
pial surface and assayed orientation selectivity of fluorescence
changes from labeled neurons in deeper cortical layers (Fig-
ures S5A–S5F). We obtained clear changes in the GCaMP3
fluorescence in response to the preferred directions, compa-
rable to those typically observed in more superficial layers.
However, unlike in superficial layers, fluorescence changes
could be observed in identified neuronal cell bodies but not in
dendritic processes. This likely reflects weaker fluorescence in
the dendrites versus cell bodies and poorer imaging signal at
greater depths.
To demonstrate the prolonged viability and visual responsive-
ness of rabies-virus-infected neurons, the same animal was
imaged again 2 days later, 11 days after the initial rabies injection
into AL. Althoughwedid not attempt to identify the same neurons
thatwere imaged at 9 days, we again identified a field of DsRedX-
expressing neurons and monitored their visual responses based
on changes in GCaMP3 fluorescence. We performed the same
set of experiments as described above to obtain orientation
selectivity tuning curves on day 9 (Figures S5G–S5L). The in-
fected cells in the V1 showed robust orientation selective fluores-
cence changes on day 11 from both GCaMP3-labeled soma and
GCaMP3-labeled dendrites at a depth of 370 mm.
From these results, we conclude that rabies-virus-mediated
expression of GCaMP3 can be used to monitor activity of
neurons targeted on the basis of their connections to more
distant neurons. Fluorescence changes can bemonitored in vivo
at either the soma or the dendrites, at depths greater than
500 mm, and virus infection does not prevent functional charac-
terization even 11 days postinfection.
Control of Neural Activity with DG Rabies Viruses
Encoding ChR2 or AlstR
Wenext developed rabies virus variants which can control neural
activity in targeted neuronal populations. To allow fast, light-
controlled neuronal activation, we used the light-activated ion
channel ChR2 fused to mCherry (Boyden et al., 2005; Nagel
et al., 2003). We recovered and amplified SADDG-ChR2-
mCherry in B7GGcells under 3%CO2, 35
Cconditions. It should
be noted that SADDG-ChR2-mCherry was difficult to recover
with our original recovery system and did not grow well under
more standard culture conditions. Nevertheless, using optimized
procedures it could be grown at titers indistinguishable from(E) Changes in fluorescence over time in response to drifting gratings at the preferr
4 s, as indicated by the black bar. Note that fluorescence was modulated at tem
gratings. These temporal modulations in phase with the visual stimuli can also be
error of the mean of DF/F values across five repetitions of the visual stimulus.GFP-expressing virus (Table 1). This difference is more likely to
relate to the gene product expressed rather than the insert
size, as similar difficulties were observed with another mem-
brane protein (AlstR, see below) but not with several other
viruses with even larger genomes (Table 1). To test the function-
ality of SADDG-ChR2-mCherry, it was injected into the S1 barrel
cortex of P8 mice. As expected from infection of neurons with
axon terminals at the injection site, 6–10 days after injection,
numerous infected neurons were observed in the neighboring
barrel cortex, as well as other structures projecting to S1, such
as the contralateral S1 cortex, M1 cortex, and the thalamic
nucleus ventral posteromedial nucleus (VPM). We performed
fluorescence-targeted whole-cell recordings from ChR2-
mCherry-positive neurons in acute slices of injected mice and
assayed their responses to photoactivation with a blue-light
emitting diode (LED) connected to a light fiber. We selected
cortical brain slices with relatively sparse labeling of ChR2-
mCherry-positive neurons in order to minimize possible network
effects that could result from simultaneous activation of large
populations of neurons. We recorded from slices prepared
from different animals at three different time points 6, 8, and
10 days postinfection. Although numerous mCherry neurons
where clearly visible in the brain slices at all time points, func-
tional activation was weaker at 6 days postinfection than at 8
or 10 days (Figure 3A). Figure 3A shows results of current-clamp
recordings from representative mCherry-expressing pyramidal
neurons located near the viral injection sites in S1, at 6, 8 and
10 days after virus injection. After recording, neurons were filled
with biocytin included in the patch pipette to confirm with later
streptavidin-Cy2 staining that the recorded cell expressed
mCherry derived from the rabies virus genome (Figure 3B). We
found that blue light pulses at 5 Hz with 2 ms duration induced
depolarization in every ChR2-mCherry-positive cell (n = 14)
regardless of time after infection (Figure 3A), as expected from
previous characterization of ChR2 (Boyden et al., 2005).
However, on day 6 after rabies infection, recordings demon-
strated that light-induced depolarizing currents using these
light levels and pulse duration were below threshold for action
potential generation in all neurons sampled (n = 5/5). Eight to
ten days after virus injection, however, the same blue light stimuli
invariably induced action potentials in ChR2-expressing neurons
(n = 5/5 on day 8; n = 4/4 on day 10). These results indicate that
rabies-virus-mediated expression of ChR2 allows reliable optical
control of infected neurons, but expression levels and/or
membrane localization at early time points are likely to be lower,
resulting in reduced sensitivity.
We also generated AlstR-encoding DG rabies to allow selec-
tive and reversible pharmacological silencing of neural activity
(Lechner et al., 2002; Tan et al., 2006; Tan et al., 2008; Zhou
et al., 2009). Expression of AlstR in mammalian neurons and
application of the AL results in openingGprotein-coupled inward
rectifier K+ channels (Birgu¨l et al., 1999), which hyperpolarizes
neurons and decreases their input resistance, thus suppressinged orientation. Time 0 indicates the onset of the visual stimulus, which lasted for
poral frequencies that correspond to the temporal frequencies of the drifting
seen in Supplemental Movies. Values in (D) and (E) represent means ± standard
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Figure 3. Photoactivation of Neurons Infected with ChR2-mCherry-
Expressing DG Rabies Virus
(A) Generation of action potentials in ChR2-mCherry-expressing neurons by
blue light pulses. Intracellular recordings were made from a layer 5 neuron in
S1 barrel cortex 6, 8, and 10 days after injection of SADDG-ChR2-mCherry in
postnatal 9-day-old mice. During current-clamp, action potentials were reli-
ably generated by blue light pulses of 5 Hz and 2ms duration on days 8 and 10
but not day 6.
(B) The recorded neuron, filled with biocytin and stained with streptavidin-Cy2
(green), was positive for mCherry (red). Scale bar represents 30 mm.
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To allow visualization of infected neurons as well as control
of their activity, we generated DG rabies encoding both GFP
and AlstR (SADDG-GFP-AlstR). We recovered and amplified
SADDG-GFP-AlstR in B7GG cells, again at 35C and with 3%
CO2. Although titers of virus grown under standard culture condi-
tions were somewhat lower than for SADDG-GFP, under these
modified culture conditions this virus could be grown to high
titers, indistinguishable from other DG rabies viruses (Table 1).
The concentrated SADDG-GFP-AlstR was injected into the
barrel field of the S1 cortex of P18 mice. We prepared acute
cortical slices of the injected mice 7 days after injection and tar-
geted whole-cell recordings to GFP-positive neurons. Record-
ings characterized the membrane potential, input resistance,
and excitability of the SADDG-GFP-AlstR-infected neurons. As
exemplified for the neuron in Figure 4, before application of alla-
tostatin (AL), resting membrane potential was 56.1 mV and
input resistance was 87.0 MU. Spike threshold was determined
by injection of a series of depolarizing current pulses, gradually624 Neuron 71, 617–631, August 25, 2011 ª2011 Elsevier Inc.increasing in amplitude, and the initial spike threshold was less
than +50 pA (Figure 4A). Application of AL (1 mM) decreased
membrane potential to 62.2 mV and input resistance to 37.3
MU. In the presence of AL, +50 pA current pulses were no longer
sufficient to induce an action potential, and even pulses
of +220 pA were still insufficient, indicating greatly reduced
excitability (Figure 4B). At 30 min after AL washout, resting
membrane potential and input resistance in the AlstR-express-
ing neuron partially recovered to59.8mV and 53.1MU, respec-
tively. The amplitude of depolarizing current pulses necessary to
elicit an action potential was +150 pA, also indicating partial
recovery (Figure 4C). After recording, we confirmed that the re-
corded cell was infected with SADDG-GFP-AlstR by colabeling
withGFPandbiocytin (stainedwith streptavidin-Cy3) (Figure 4D).
Incomplete recovery is likely due to failure to completely remove
AL from the recording chamber during washout. Silencing
effects by AL were also observed 5 days after injection of
SADDG-GFP-AlstR (n = 2/2). At 13–15 days postinjection,
however, infected cells exhibited relatively depolarized resting
membrane potentials (from 30 mV to 40mV), although cell
morphology appeared intact (n = 10/10). Poor cell health at 13–
15 days is expected, as some rabies-virus-infected cells are
likely killed by this time point (Wickersham et al., 2007a). It is
possible that such effects are also exacerbated by expression
of high levels of amembrane protein such as AlstR. These results
indicate that AlstR expressed from the rabies virus is functional,
and all results are consistent with far more rigorous characteriza-
tions that have been conducted previously (Lechner et al., 2002;
Tan et al., 2006).
Temporal Control of Gene Expression and
Transsynaptic Viral Tracing fromaGenetically-Targeted
Single Postsynaptic Neuron
Genetic methods for the control of gene expression, such as the
Cre-lox, the FLP-frt, and the TetO/rtTA (Tet-On) systems, have
widespread and powerful applications. We envision numerous
applications for rabies viruses that encode Cre-recombinase,
FLP-recombinase, or rtTA in their genomes. These include
temporal control of the spread of virus across multiple synaptic
steps and the ability to interface with Cre and tTA responder
mouse lines or viral vectors. For example, using a Cre-express-
ing rabies in Brainbow mice (Livet et al., 2007) could allow
labeling of the inputs to single neurons (Marshel et al., 2010;
Wickersham et al., 2007b), with the individual presynaptic cells
each uniquely marked by expression of different combinations
of fluorescent protein. Interfacing with responder mice that
conditionally express rabies glycoprotein (Weible et al., 2010)
could potentially allow temporal control of the spread of DG
rabies iteratively across multiple synaptic steps. While we do
not explore all of these possibilities here, we describe the devel-
opment of DG rabies viruses expressing genes that allow control
of gene expression and demonstrate that these viruses can be
grown to high titer and that the gene products are functional in
rabies-virus-infected cells.
Using methods described above, we made three new
variants of rabies virus, each encoding both a fluorescent
marker gene and another protein for control of gene expression.
These include reverse tTA (rtTA) (Urlinger et al., 2000), which
AB
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Figure 4. Allatostatin-Induced Silencing of
Neural Activity with AlstR-Expressing DG
Rabies Virus
(A–C) Whole-cell current clamp recordings from
a pyramidal neuron in a brain slice from the barrel
cortex of an 18-day-old mouse 7 days after
injection of SADDG-GFP-AlstR. (A) Before appli-
cation of allatostatin (AL), representative traces of
responses to depolarizing current pulses
(+50, +100, +150, and +200 pA; 750 ms duration)
show that multiple action potentials are generated
with as little as +50 pA. (B) Application of the ligand
AL at 1 mM inactivated the SADDG-GFP-AlstR-
infected neuron; +200 pA of current could no
longer generate action potentials in the presence
of AL. (C) The effects of AL were partially reversed
by washout of AL with normal ACSF; +150 pA
induced action potentials after washout of AL.
(D) Photographs of the recorded neuron as well as
neighboring infected neurons. The recorded
neuron was filled with biocytin and stained with
streptavidin-Cy3 (red), and was positive for GFP
derived from SADDG-GFP-AlstR (green). Scale
bar represents 30 mm.
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Rabies Virus Variants for Neural Circuit Researchrequires doxycycline (dox) for activation; tamoxifen-inducible
Cre-recombinase (ERT2CreERT2) (Matsuda and Cepko, 2007;
Young et al., 2008); and FLP-recombinase (FLPo) (Raymond and
Soriano, 2007; Zhu and Sadowski, 1995). The resulting viruses
are called SADDG-GFP-rtTA, SADDG-GFP-ERT2CreERT2, and
SADDG-FLPo-DsRedX, respectively, and all could be grown to
high titers (Table 1).
To illustrate the utility of SADDG-GFP-rtTA for analyzing neural
circuits, we demonstrate dox-dependent transsynaptic spread
from genetically-targeted neurons. Previously, we established
a tracing method that uses EnvA-pseudotyped SADDG-GFP to
selectively label the neurons that are directly presynaptic to
a single, genetically-targeted postsynaptic neuron (Wickersham
et al., 2007b). With this system, the transsynaptic spread of
DG rabies virus was dependent on complementation by rabies
glycoprotein expressed constitutively in the targeted post-
synaptic neuron. Here we demonstrate conditional and temporal
control of viral spread by placing rabies glycoprotein expres-
sion under the control of the TetO promoter and using the
SADDG-GFP-rtTA rabies virus.We constructed a plasmid condi-
tionally expressing both nuclear-localized mCherry and rabies
glycoprotein B19G linked by an F2A self-cleaving element and
a GSG linker (Ryan and Drew, 1994; Szymczak et al., 2004),
under the control of the TetO promoter (pTetO-H2B-mCherry-Neuron 71, 617–6312A-rabies glycoprotein) (Figure 5). Biolis-
tics was used to cotransfect neurons in
organotypic cortical slice cultures with
both pTetO-H2B-mCherry-2A-rabies
glycoprotein and pCMMP-TVA800. In
pCMMP-TVA800, the CMV promoter
drives the expression of TVA, a cognate
receptor for the envelope protein EnvA.
(Wickersham et al., 2007b). We then
applied EnvA-pseudotyped SADDG-GFP-rtTA to the transfected slice cultures either in the presence
or absence of dox, an analog of tetracycline (1.0 mg/ml). As ex-
pected from previous studies (Wickersham et al., 2007b) as
well as dox- and rtTA-dependent expression of mCherry and
rabies glycoprotein, in the presence of dox, the EnvA-pseudo-
typed virus selectively infected TVA-transfected neurons,
which subsequently expressed mCherry as well as rabies
glycoprotein; this expression allowed transcomplementation
so that the rabies virus spread to numerous nearby presynaptic
neurons, which expressed GFP from the rabies genome (Fig-
ure 5A). In contrast, in the absence of dox, GFP expression
from the rabies genome was restricted to isolated neurons that
were presumably transfected and expressed TVA but did not
express mCherry (Figure 5B). This result demonstrated the
requirement for the presence of dox to allow the originally-
infected, isolated neurons to express mCherry and rabies
glycoprotein, which is required for transsynaptic labeling of
neighboring neurons.
To test the rabies virus expressing tamoxifen-inducible Cre-
recombinase (SADDG-GFP-ERT2CreERT2), HEK293t cells were
transfected with a reporter plasmid expressing a loxP-STOP-
loxP DsRed casette (pCALNL-DsRed) and then infected with
SADDG-GFP-ERT2CreERT2. In the presence of 4-hydroxyta-
moxifen (4-HOT), Cre recombined pCALNL-DsRed and, August 25, 2011 ª2011 Elsevier Inc. 625
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Figure 5. Doxycycline-Dependent Gene Expres-
sion and Conditional Transsynaptic Spread with
SADDG-GFP-rtTA Rabies Virus
(A and B) Following biolistic transfection of isolated
neurons in rat cortical slice culture with both pTetO-
CMVmin-Histone2B-mCherry-F2A-B19G and pCMMP-
TVA, application of EnvA-pseudotyped SADDG-GFP-rtTA
resulted in selective infection of transfected neurons. (A)
The presence of both dox and rtTA expressed from the
rabies virus allowedmCherry expression in EnvA-SADDG-
GFP-rtTA-infected neurons as shown by the yellow (GFP
andmCherry) appearance of the soma of the postsynaptic
neuron. The expression of rabies glycoprotein in this
same postsynaptic neuron allowed complementation of
the DG rabies so that the virus could spread to and
express GFP in numerous presynaptic neurons. (B) Under
the same conditions in the absence of dox (1.0 mg/ml), the
EnvA-SADDG-GFP-rtTA rabies virus also selectively in-
fected scattered, isolated TVA-expressing neurons. But
without dox there was no mCherry or rabies glycoprotein
expression and therefore no complementation or trans-
synaptic spread of the rabies virus. Only three transfected
and primarily infected neurons (green cells indicated
by arrows) could be found in the brain slice in the
absence of dox. Scale bars represent 100 mm (right) and
50 mm (left).
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Rabies Virus Variants for Neural Circuit Researchcoexpression of both GFP and DsRed was observed. However,
without tamoxifen, only GFP expression was observed. These
results indicate that tamoxifen controls Cre-dependent recombi-
nation in rabies-virus-infected cells (Figure 6A).
Similarly, we tested SADDG-FLPo-DsRedX rabies virus by
using both HEK293t cells and HeLa cells stably expressing
a frt-STOP-frt nuclear-localized LacZ casette. SADDG-FLPo-
DsRedX-infected HEK293t cells had red fluorescence (Fig-
ure 6B). Only cells that express FLPo from the rabies genome
excise a frt-flanked STOP signal and activate constitutive LacZ
expression. X-gal staining demonstrated that the SADDG-
FLPo-DsRedX virus caused recombination and LacZ expression
in the HeLa cells (Figure 6C), whereas no LacZ expression was
detected in the absence of the virus expressing FLPo (Figure 6D).
These observations indicate functional recombination by FLPo
derived from rabies virus.
DISCUSSION
We have described the development of a set of DNA plasmids
suitable for generation of new genetically-modified variants of
SADDG rabies viruses.We have used these reagents to generate
12 new SADDG rabies virus variants that express transgenes of626 Neuron 71, 617–631, August 25, 2011 ª2011 Elsevier Inc.broad utility. These include DG rabies virus vari-
ants expressing two exogenous genes from the
same rabies genome, as well as viruses to
combine rabies labeling with monitoring or
manipulating neuronal activity, and finally new
variants expressing genes to allow control of
gene expression within infected neurons.
Furthermore, we have demonstrated the utility
of these viruses for directly correlating connec-tivity with function in the intact brain and for manipulating activity
or controlling gene expression in live cells. These new variants
can now be propagated indefinitely and are available for use.
These tools are expected to be an important component of
a growing arsenal of genetic tools for the study of neural circuits
(Luo et al., 2008) and open the door to new approaches for circuit
research, whereby neuronal connectivity can be directly related
to circuit function.
Strengths and Limitations of DG Rabies Virus
Many recently published studies have demonstrated the tremen-
dous advantages of DG rabies viruses for tracing neural circuits
at high resolution. For example, it is possible to retrogradely
infect neurons and express fluorescent proteins at high levels
for detailed anatomical investigations (Larsen et al., 2007; Nassi
and Callaway, 2007; Wickersham et al., 2007a); to identify
neurons that are directly presynaptic to specific types of projec-
tion neurons (Stepien et al., 2010; Yonehara et al., 2011); to
identify neurons that are directly presynaptic to specific geneti-
cally-defined cell types (Haubensak et al., 2010; Miyamichi
et al., 2011; Wall et al., 2010); and to identify neurons that are
directly presynaptic to single, functionally-characterized
neurons (Marshel et al., 2010; Rancz et al., 2011).
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Figure 6. Recombination-Dependent Gene Ex-
pression by ERT2CreERT2 or FLPo DG Rabies
Viruses
(A) Temporal regulation of gene expression with inducible
Cre-recombinase. SADDG-GFP-ERT2CreERT2 activates
tamoxifen-dependent expression of DsRed in HEK293t
cells transfected with pCALNL-DsRed (recombination
indicator). Top and Bottom: results in the presence and
absence of tamoxifen (+4HOT, 1 nM), respectively. Left:
GFP expression from the rabies genome; (middle) Cre-
induced DsRed expression in the presence of 4HOT (top)
but not in the absence of 4HOT (bottom); and overlays in
right panels. Scale bar represents 100 mm.
(B) SADDG-FLPo-DsRedX-infected cells expressed a red
fluorescent DsRedX in HEK293t cells 3 days after virus
infection. Scale bar represents 100 mm.
(C and D) Recombination induced in SADDG-FLPo-
DsRedX-infected cells. X-gal staining showed that HeLa
cells stably expressing frt-STOP-frt LacZ cassette
(recombination indicator) expressed LacZ in the presence
of SADDG-FLPo-DsRedX (C), but not in the absence of
SADDG-FLPo-DsRedX (D). Scale bar represents 300 mm.
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Rabies Virus Variants for Neural Circuit ResearchAll of these studies traced connections in vivo, suggesting
that they could be combined with methods for imaging or
manipulating live neurons in the intact nervous system, as we
have demonstrated here. The utility of these viruses for such
studies depends on the ability of DG rabies virus to infect cells
and drive high levels of viral gene expression without killing
them. Previously it has been shown that basic properties of
infected neurons are not altered by infection after 7 days but
that many neurons are killed by about 14 days after infection
(Wickersham et al., 2007a). We have shown here that there
exists a working time window between about 5 and 11 days
postinfection when functional studies of infected neurons are
feasible. Nevertheless, it is important for users to consider
possible unwanted affects of rabies infection that may be unique
to any of the various experimental conditions that might be used.
For example, rabies virus infection can reduce expression of
genes from the infected cells (Weible et al., 2010) and our
experiments with AlstR-expressing rabies virus show that at
13–15 days postinfection, live neurons display altered physio-
logical properties. It is therefore crucial for potential users of
these reagents to test and to control for any adverse affects of
rabies virus infection. Despite these limitations, rabies virus is
the only neurotropic virus we are aware of in which such studies
directly linking connectivity to function over a time window as
long as 6 days would be possible, as other viruses such as
HSV and PRV kill neurons much more rapidly (Brittle et al.,
2004; Card and Enquist, 2001).Neuron 71, 6It is also important to consider possible
effects of high levels of transgene expression.
For many experiments, the high levels of gene
expression that are obtained with rabies
viruses, relative to replication-incompetent
viruses (e.g., Wickersham et al., 2007a) are
advantageous. GFP expressed at high levels
allows detailed anatomical reconstructions
(Larsen et al., 2007; Nassi and Callaway,2007); ChR2 must be expressed at high levels for optogenetic
control of activity (Figure 3), and high levels of fluorescent protein
likely facilitate two-photon imaging of neurons deep within live
brain tissue (Figure 2B). While some transgenes have been re-
ported to have toxicity at high expression levels, successful
generation of transgenic and knock-in animals expressing
GFP,mCherry, GCaMP, ChR2, AlstR, rtTA, tTA, Cre, or FLP (Are-
nkiel et al., 2007; Dı´ez-Garcı´a et al., 2007; Gosgnach et al., 2006;
Hippenmeyer et al., 2005; Tsien et al., 1996) suggest that
moderate expression of these genes is well-tolerated for long
time periods. It is therefore important for users to consider
possible effects of high-level transgene expression from DG
rabies viruses; however, effects over long time periods are likely
to be moot, as the virus will likely kill neurons of interest before
such issues are relevant. In cases where high levels of expres-
sion of a particularly toxic gene product are a concern during
the limited period when rabies-virus-infected neurons are viable,
it may be possible to drive transgene expression from a less effi-
cient means, such as in a transgenic animal, under the control of
rtTA, Cre-ER, or FLPo expressed from the rabies genome (e.g.,
Figure 5).
The utility of the novel rabies variants we have described
here also depends on the degree to which they behave similarly
to the better characterized DG rabies viruses expressing GFP
or mCherry. For example, efficient infection is an important
feature that is likely determined primarily by the titers at which
these viruses can be grown and purified. We observed that17–631, August 25, 2011 ª2011 Elsevier Inc. 627
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Rabies Virus Variants for Neural Circuit ResearchChR2 and AlstR-expressing DG rabies viruses were more diffi-
cult to grow than GFP-expressing virus, but with modified
culture conditions they could be made at high titers that were
indistinguishable from GFP-expressing viruses (Table 1). Within
the limited range of insert sizes that we tested, there was no
consistent relationship or apparent affect on viral titers (Table 1).
For example, the largest genome we have recovered is for
SADDG-GFP-ERT2CreERT2, which includes GFP (0.7 kb) and
ERT2CreERT2 (2.9 kb) as well as four native viral genes (N, P,
M, and L) for total of 13.6 kb, which is 1.7 kb larger than the native
SAD-B19 genome of 11.9 kb (Conzelmann et al., 1990). After
recovery, this rabies virus was amplified as efficiently as the
SADDG-GFP rabies virus (10.2 kb genome). While in our hands
neither the transgene expressed nor the size of the viral genome
prevented production of high-titer DG rabies viruses, it is likely
that the utility of these viruses will depend on the skill and care
taken by those who grow them as well as careful adherence to
the established protocols we have developed.
Linking Connectivity to Function
One of the main goals of systems neuroscience is to understand
the architecture and function of neural circuits. Understanding
how neural circuits function will require resolving the connectivity
of the components; correlating the function of components with
their connectivity; manipulating the activity of selected compo-
nents and monitoring the activity of other components within
the networks; and finally, assessing the behavioral outcome.
Techniques for achieving these goals, however, are limited.
The rabies tools we have described here provide many new
opportunities to allow the combination of rabies-virus-based
circuit tracing with functional studies.
For example, expression of the calcium sensor GCaMP3 in
neurons that have been infected as a result of their connectivity
with specific cell types or a single neuron could allow observa-
tions of direct correlations between connectivity and function
in a single living preparation. Here we have explicitly demon-
strated this type of approach by combining retrograde infection
with GCaMP3-expressing DG rabies virus with in vivo two-
photon imaging of visual responses. This allowed measure-
ments of the visual receptive fields of a specific subset of
mouse V1 neurons selected on the basis of their connectivity
to area AL.
Similarly, expression of ChR2 andAlstR should allow control of
neural activities in vitro and in vivo and facilitate tests of the
causal relationships between connectivity and function within
defined neural circuits. It should also be possible to test possible
postsynaptic targets of connectionally-targeted rabies-virus-
infected neurons for functional connectivity with potential post-
synaptic neurons through intracellular recording combined with
photoactivation of axons from neurons expressing ChR2 from
the rabies genome (Petreanu et al., 2007).
Targeting infection and transsynaptic labeling with GCaMP3-
DG, ChR2-DG, and AlstR-DG rabies in defined cell types or
single cells with retrograde infection (Stepien et al., 2010; Wick-
ersham et al., 2007a; Wickersham et al., 2007b; Yonehara et al.,
2011), Cre-dependent TVA transduction (Haubensak et al., 2010;
Wall et al., 2010), bridge proteins with TVB (Choi et al., 2010), or
single cell electroporation of TVA (Marshel et al., 2010; Rancz628 Neuron 71, 617–631, August 25, 2011 ª2011 Elsevier Inc.et al., 2011) will be extremely useful for functional studies of
identified neural circuits. In particular, by taking advantage of
an increasing number of Cre-expressing mouse lines for target-
ing particular cell types (Driver lines are available in GENSAT and
the Allen Institute for Brain Science), researchers will have an
unprecedented opportunity to reveal detailed connectivity and
function of specific cell types in mice (Madisen et al., 2010;
Wall et al., 2010).
Finally, the expression of tamoxifen-inducible Cre, FLPo, or
rtTA from the rabies genome will allow conditional expression
of transgenes, such as transcription factors. In particular, inter-
facing DG rabies viruses with the increasing number of mouse
lines and viral vectors that express rabies glycoprotein in
a Cre-, FLPo-, or tTA-dependent manner (Weible et al., 2010)
might allow for temporally-controlled tracing across multiple
synaptic steps by administration of tamoxifen or doxycycline.
In conclusion, the new reagents that we have developed are
expected to facilitate future studies of nervous system function
by allowing neuronal connectivity to be directly related to
function.EXPERIMENTAL PROCEDURES
Production of DG Rabies Virus
Genomic RNA of SADDG-GFP rabies virus was purified and reverse tran-
scribed to obtain partial cDNA fragments of the rabies virus genome. We
cloned rabies nucleocapsid (pcDNA-SADB19N), rabies viral RNA polymerases
(pcDNA-SADB19P and pcDNA-SADB19L), or rabies glycoprotein (pcDNA-
SADB19G) by using PCR. To construct the rabies virus genomic cDNA, we
ligated several pieces of rabies genomic cDNA and flanked them by HamRz
and HdvRz in pcDNA3.1, which then became pcDNA-SADDG-GFP. To estab-
lish a two gene expression system in the rabies genome, we synthesized and
cloned transcription stop and start sequences and six unique restriction
enzyme sites to produce pSADDG-F3.
For recovery of DG rabies virus, B7GG cells were transfected with the rabies
genome pSADDG vector, pcDNA-SADB19N, pcDNA-SADB19P, pcDNA-
SADB19L, and pcDNA-SADB19G and maintained in a humidified atmosphere
of 3% CO2 at 35
C. For pseudotyping with EnvA, BHK-EnvA cells were
infected with unpseudotyped SADDG rabies viruses, washed with PBS,
reacted with 0.25% trypsin-EDTA, and replated on new dishes. For in vivo
injection, DG rabies viruses were amplified in ten 15 cm dishes in a humidified
atmosphere of 3% CO2 at 35
C, filtrated with 0.45 mm filter, and concentrated
by two rounds of ultracentrifugation. Unpseudotyped rabies viruses and
EnvA-pseudotyped rabies viruses were titrated with HEK293t cells and
HEK293-TVA cells, respectively. The titers and transgene size of viruses are
shown in Table 1.
Characterization of Rabies Virus Variants
DG rabies viruses were injected into the LGN, V1, AL, or S1 of mice or rats.
SADDG-GCaMP3 and SADDG-GCaMP3-DsRedX were injected in V1 and
AL of adult mice, respectively. GCaMP3 signals in the V1 were imaged with
a two-photon microscope. Visual receptive fields were assayed using drifting
square-wave gratings moving in various directions. SADDG-ChR2-mCherry
and SADDG-GFP-AlstR were injected into the barrel cortex of mice aged
from postnatal day 8 and day 18, respectively. Whole-cell recordings of
infected neurons were performed on brain slices. For photostimulation of
ChR2-expressing neurons, light stimuli were delivered at 0.2–5 Hz from
a blue LED. For inactivation of AlstR-expressing neurons, the peptide ligand
AL (Ser-Arg-Pro-Tyr-Ser-Phe-Gly-Leu-NH2) was applied by perfusion.
Organotypic brain slice cultures were used for testing SADDG-GFP-rtTA.
After biolistic transfection of both pCMMP-TVA800 and pTetO-CMVmin-
Histone2B-mCherry-F2A-B19G, slices were infected with EnvA-SADDG-
GFP-rtTA and maintained in the absence or presence of dox (1.0 mg/ml). For
Neuron
Rabies Virus Variants for Neural Circuit Researchtesting SADDG-GFP-ERT2CreERT2, HEK293t cells were transfected with the
Cre-dependent plasmid pCALNL-DsRed, infected with the rabies virus, and
maintained in the absence or presence of 4-HOT (1.0 mM). For testing
SADDG-FLPo-DsRedX, HeLa cells stably expressing a frt-STOP-frt nuclear-
localized LacZ cassette were infected with the virus and then processed for
X-gal staining.
Full methods are available in Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Experimental Procedures, five figures, and
three movies and can be found with this article online at doi:10.1016/j.neuron.
2011.07.005.
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